• Mon, April 18, 2022

by: WOPRAI

Justin Jenkins Maintained (BP) at Buy with Increased Target to $39 on, Apr 18th, 2022

by: WOPRAI

Weston Bloomer Initiated (BRO) at Hold and Held Target at $76 on, Apr 18th, 2022

by: WOPRAI

Joseph Quatrochi Maintained (AMAT) at Buy with Decreased Target to $135 on, Apr 18th, 2022

by: WOPRAI

Donald Fandetti Maintained (ALLY) at Buy with Decreased Target to $50 on, Apr 18th, 2022

by: WOPRAI

David Long Maintained (ALLY) at Buy with Decreased Target to $50 on, Apr 18th, 2022

by: WOPRAI

Kevin Barker Maintained (ALLY) at Hold with Decreased Target to $47 on, Apr 18th, 2022

by: WOPRAI

James Fotheringham Maintained (C) at Buy with Decreased Target to $78 on, Apr 18th, 2022

by: WOPRAI

Michael Sison Maintained (AVNT) at Buy with Decreased Target to $60 on, Apr 18th, 2022

by: WOPRAI

Andrew Cooper Maintained (AVTR) at Buy with Decreased Target to $40 on, Apr 18th, 2022

by: WOPRAI

Vijay Kumar Maintained (AVTR) at Buy and Held Target at $42 on, Apr 18th, 2022

by: WOPRAI

Joseph Quatrochi Maintained (ASML) at Buy with Decreased Target to $750 on, Apr 18th, 2022

by: WOPRAI

Michael Sison Maintained (ASH) at Hold with Increased Target to $113 on, Apr 18th, 2022

by: WOPRAI

Michael Sison Maintained (AXTA) at Hold with Decreased Target to $27 on, Apr 18th, 2022

by: WOPRAI

David Begleiter Downgraded (AXTA) to Hold and Decreased Target to $27 on, Apr 18th, 2022

by: WOPRAI

Michael Sison Maintained (APD) at Buy with Decreased Target to $275 on, Apr 18th, 2022

by: WOPRAI

Nathan Jones Maintained (AOS) at Hold with Decreased Target to $73 on, Apr 18th, 2022

by: WOPRAI

Alexander Potter Downgraded (APTV) to Sell and Decreased Target to $90 on, Apr 18th, 2022

by: WOPRAI

Mohit Bansal Upgraded (BIIB) to Buy and Increased Target to $265 on, Apr 18th, 2022

by: WOPRAI

Kyle White Maintained (BERY) at Strong Buy with Decreased Target to $71 on, Apr 18th, 2022

by: WOPRAI

Gena Wang Downgraded (BCRX) to Hold and Decreased Target to $13 on, Apr 18th, 2022

by: WOPRAI

Weston Bloomer Initiated (AJG) at Hold and Held Target at $192 on, Apr 18th, 2022

by: WOPRAI

Courtney Yakavonis Maintained (AGCO) at Buy with Decreased Target to $158 on, Apr 18th, 2022

by: WOPRAI

David George Upgraded (ZION) to Hold and Increased Target to $60 on, Apr 18th, 2022

by: WOPRAI

Matthew Carletti Maintained (ACGL) at Buy and Held Target at $55 on, Apr 18th, 2022

by: WOPRAI

Alexander Potter Maintained (TSLA) at Buy with Decreased Target to $420 on, Apr 18th, 2022

by: WOPRAI

Robert LeBoyer Initiated (TNXP) at Buy on, Apr 18th, 2022

by: WOPRAI

Edward White Maintained (TGTX) at Strong Buy with Decreased Target to $19 on, Apr 18th, 2022

by: WOPRAI

Courtney Yakavonis Maintained (TKR) at Hold with Decreased Target to $72 on, Apr 18th, 2022

by: WOPRAI

John Pancari Maintained (TFC) at Buy and Held Target at $62 on, Apr 18th, 2022

by: WOPRAI

Courtney Yakavonis Maintained (TEX) at Hold with Decreased Target to $48 on, Apr 18th, 2022

by: WOPRAI

Vijay Rakesh Maintained (SYNA) at Strong Buy with Decreased Target to $250 on, Apr 18th, 2022

by: WOPRAI

Vijay Rakesh Maintained (SWKS) at Strong Buy with Decreased Target to $175 on, Apr 18th, 2022

by: WOPRAI

Courtney Yakavonis Maintained (SUM) at Hold with Decreased Target to $40 on, Apr 18th, 2022

by: WOPRAI

Mike Mayo Maintained (STT) at Hold with Decreased Target to $95 on, Apr 18th, 2022

by: WOPRAI

Susan Roth Katzke Maintained (STT) at Hold with Decreased Target to $90 on, Apr 18th, 2022

by: WOPRAI

Brian Bedell Maintained (STT) at Strong Buy with Decreased Target to $100 on, Apr 18th, 2022

by: WOPRAI

Betsy Graseck Maintained (STT) at Buy with Decreased Target to $112 on, Apr 18th, 2022

by: WOPRAI

Patrick Tyler Brown Maintained (CSX) at Buy with Decreased Target to $39 on, Apr 18th, 2022

by: WOPRAI

Cherilyn Radbourne Downgraded (CSX) to Hold and Decreased Target to $38 on, Apr 18th, 2022

by: WOPRAI

Steve Byrne Maintained (CE) at Hold with Increased Target to $174 on, Apr 18th, 2022

by: WOPRAI

Colin Bristow Maintained (CCCC) at Strong Buy with Decreased Target to $26 on, Apr 18th, 2022

by: WOPRAI

Raghuram Selvaraju Maintained (CDXC) at Strong Buy with Decreased Target to $8 on, Apr 18th, 2022

by: WOPRAI

Raghuram Selvaraju Maintained (SPRO) at Strong Buy with Decreased Target to $37 on, Apr 18th, 2022

by: WOPRAI

Julien Dumoulin-Smith Upgraded (SR) to Hold and Held Target at $79 on, Apr 18th, 2022

by: WOPRAI

Jeffrey Silber Maintained (SPGI) at Buy with Increased Target to $462 on, Apr 18th, 2022

by: WOPRAI

Alexander Goldfarb Maintained (SOHO) at Hold with Decreased Target to $2.5 on, Apr 18th, 2022

by: WOPRAI

Curtis Nagle Maintained (SNBR) at Sell with Decreased Target to $45 on, Apr 18th, 2022

by: WOPRAI

Ian Macpherson Maintained (XPRO) at Hold with Increased Target to $23 on, Apr 18th, 2022

Gena Wang Downgraded (BCRX) to Hold and Decreased Target to $13 on, Apr 18th, 2022

Gena Wang of Barclays, Downgraded "BioCryst Pharmaceuticals, Inc." (BCRX) to Hold and Decreased Target from $22 to $13 on, Apr 18th, 2022.

Gena has made no other calls on BCRX in the last 4 months.



There are 3 other peers that have a rating on BCRX. Out of the 3 peers that are also analyzing BCRX, 2 agree with Gena's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $14 on, Tuesday, April 12th, 2022
  • Tazeen Ahmad of "B of A Securities" Downgraded from Strong Buy to Hold and Held Target at $14 on, Monday, April 11th, 2022


This is the rating of the analyst that currently disagrees with Gena

  • Justin Kim of "Oppenheimer" Maintained at Buy with Decreased Target to $16 on, Monday, April 11th, 2022

Like: 👍